[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Virus Like Particles Market Professional Survey Report 2017

November 2017 | 116 pages | ID: G61FF8F811BWEN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies Virus Like Particles in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
  • GlaxoSmithKline
  • Merck
  • Novavax
  • Takeda
  • Medicago
  • MedImmune
  • TechnoVax
  • Agilvax
  • Allergy Therapeutics
  • Serum Institute of India
  • GeoVax Labs
  • Cytos Biotechnology
  • ANGANY Genetics
  • CPL Biologicals
  • Xiamen Innovax Biotech
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Adeno-Associated Virus
  • HIV
  • Hepatitis B Virus
  • Hepatitis C Virus
  • Other
By Application, the market can be split into
  • Vaccines
  • Mycoviruses
  • Virus Research
  • Therapeutic and Imaging Agents
  • Other
By Regions, this report covers (we can add the regions/countries as you want)
  • North America
  • China
  • Europe
  • Southeast Asia
  • Japan
  • India
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Virus Like Particles Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF VIRUS LIKE PARTICLES

1.1 Definition and Specifications of Virus Like Particles
  1.1.1 Definition of Virus Like Particles
  1.1.2 Specifications of Virus Like Particles
1.2 Classification of Virus Like Particles
  1.2.1 Adeno-Associated Virus
  1.2.2 HIV
  1.2.3 Hepatitis B Virus
  1.2.4 Hepatitis C Virus
  1.2.5 Other
1.3 Applications of Virus Like Particles
  1.3.1 Vaccines
  1.3.2 Mycoviruses
  1.3.3 Virus Research
  1.3.4 Therapeutic and Imaging Agents
  1.3.5 Other
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF VIRUS LIKE PARTICLES

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Virus Like Particles
2.3 Manufacturing Process Analysis of Virus Like Particles
2.4 Industry Chain Structure of Virus Like Particles

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF VIRUS LIKE PARTICLES

3.1 Capacity and Commercial Production Date of Global Virus Like Particles Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Virus Like Particles Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Virus Like Particles Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Virus Like Particles Major Manufacturers in 2016

4 GLOBAL VIRUS LIKE PARTICLES OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Virus Like Particles Capacity and Growth Rate Analysis
  4.2.2 2016 Virus Like Particles Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Virus Like Particles Sales and Growth Rate Analysis
  4.3.2 2016 Virus Like Particles Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Virus Like Particles Sales Price
  4.4.2 2016 Virus Like Particles Sales Price Analysis (Company Segment)

5 VIRUS LIKE PARTICLES REGIONAL MARKET ANALYSIS

5.1 North America Virus Like Particles Market Analysis
  5.1.1 North America Virus Like Particles Market Overview
  5.1.2 North America 2012-2017E Virus Like Particles Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Virus Like Particles Sales Price Analysis
  5.1.4 North America 2016 Virus Like Particles Market Share Analysis
5.2 China Virus Like Particles Market Analysis
  5.2.1 China Virus Like Particles Market Overview
  5.2.2 China 2012-2017E Virus Like Particles Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Virus Like Particles Sales Price Analysis
  5.2.4 China 2016 Virus Like Particles Market Share Analysis
5.3 Europe Virus Like Particles Market Analysis
  5.3.1 Europe Virus Like Particles Market Overview
  5.3.2 Europe 2012-2017E Virus Like Particles Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Virus Like Particles Sales Price Analysis
  5.3.4 Europe 2016 Virus Like Particles Market Share Analysis
5.4 Southeast Asia Virus Like Particles Market Analysis
  5.4.1 Southeast Asia Virus Like Particles Market Overview
  5.4.2 Southeast Asia 2012-2017E Virus Like Particles Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Virus Like Particles Sales Price Analysis
  5.4.4 Southeast Asia 2016 Virus Like Particles Market Share Analysis
5.5 Japan Virus Like Particles Market Analysis
  5.5.1 Japan Virus Like Particles Market Overview
  5.5.2 Japan 2012-2017E Virus Like Particles Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Virus Like Particles Sales Price Analysis
  5.5.4 Japan 2016 Virus Like Particles Market Share Analysis
5.6 India Virus Like Particles Market Analysis
  5.6.1 India Virus Like Particles Market Overview
  5.6.2 India 2012-2017E Virus Like Particles Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Virus Like Particles Sales Price Analysis
  5.6.4 India 2016 Virus Like Particles Market Share Analysis

6 GLOBAL 2012-2017E VIRUS LIKE PARTICLES SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Virus Like Particles Sales by Type
6.2 Different Types of Virus Like Particles Product Interview Price Analysis
6.3 Different Types of Virus Like Particles Product Driving Factors Analysis
  6.3.1 Adeno-Associated Virus of Virus Like Particles Growth Driving Factor Analysis
  6.3.2 HIV of Virus Like Particles Growth Driving Factor Analysis
  6.3.3 Hepatitis B Virus of Virus Like Particles Growth Driving Factor Analysis
  6.3.4 Hepatitis C Virus of Virus Like Particles Growth Driving Factor Analysis
  6.3.5 Other of Virus Like Particles Growth Driving Factor Analysis

7 GLOBAL 2012-2017E VIRUS LIKE PARTICLES SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Virus Like Particles Consumption by Application
7.2 Different Application of Virus Like Particles Product Interview Price Analysis
7.3 Different Application of Virus Like Particles Product Driving Factors Analysis
  7.3.1 Vaccines of Virus Like Particles Growth Driving Factor Analysis
  7.3.2 Mycoviruses of Virus Like Particles Growth Driving Factor Analysis
  7.3.3 Virus Research of Virus Like Particles Growth Driving Factor Analysis
  7.3.4 Therapeutic and Imaging Agents of Virus Like Particles Growth Driving Factor Analysis
  7.3.5 Other of Virus Like Particles Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF VIRUS LIKE PARTICLES

8.1 GlaxoSmithKline
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 GlaxoSmithKline 2016 Virus Like Particles Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 GlaxoSmithKline 2016 Virus Like Particles Business Region Distribution Analysis
8.2 Merck
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Merck 2016 Virus Like Particles Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Merck 2016 Virus Like Particles Business Region Distribution Analysis
8.3 Novavax
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Novavax 2016 Virus Like Particles Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Novavax 2016 Virus Like Particles Business Region Distribution Analysis
8.4 Takeda
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Takeda 2016 Virus Like Particles Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Takeda 2016 Virus Like Particles Business Region Distribution Analysis
8.5 Medicago
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Medicago 2016 Virus Like Particles Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Medicago 2016 Virus Like Particles Business Region Distribution Analysis
8.6 MedImmune
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 MedImmune 2016 Virus Like Particles Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 MedImmune 2016 Virus Like Particles Business Region Distribution Analysis
8.7 TechnoVax
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 TechnoVax 2016 Virus Like Particles Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 TechnoVax 2016 Virus Like Particles Business Region Distribution Analysis
8.8 Agilvax
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Agilvax 2016 Virus Like Particles Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Agilvax 2016 Virus Like Particles Business Region Distribution Analysis
8.9 Allergy Therapeutics
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Allergy Therapeutics 2016 Virus Like Particles Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Allergy Therapeutics 2016 Virus Like Particles Business Region Distribution Analysis
8.10 Serum Institute of India
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Serum Institute of India 2016 Virus Like Particles Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Serum Institute of India 2016 Virus Like Particles Business Region Distribution Analysis
8.11 GeoVax Labs
8.12 Cytos Biotechnology
8.13 ANGANY Genetics
8.14 CPL Biologicals
8.15 Xiamen Innovax Biotech

9 DEVELOPMENT TREND OF ANALYSIS OF VIRUS LIKE PARTICLES MARKET

9.1 Global Virus Like Particles Market Trend Analysis
  9.1.1 Global 2017-2022 Virus Like Particles Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Virus Like Particles Sales Price Forecast
9.2 Virus Like Particles Regional Market Trend
  9.2.1 North America 2017-2022 Virus Like Particles Consumption Forecast
  9.2.2 China 2017-2022 Virus Like Particles Consumption Forecast
  9.2.3 Europe 2017-2022 Virus Like Particles Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Virus Like Particles Consumption Forecast
  9.2.5 Japan 2017-2022 Virus Like Particles Consumption Forecast
  9.2.6 India 2017-2022 Virus Like Particles Consumption Forecast
9.3 Virus Like Particles Market Trend (Product Type)
9.4 Virus Like Particles Market Trend (Application)

10 VIRUS LIKE PARTICLES MARKETING TYPE ANALYSIS

10.1 Virus Like Particles Regional Marketing Type Analysis
10.2 Virus Like Particles International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Virus Like Particles by Region
10.4 Virus Like Particles Supply Chain Analysis

11 CONSUMERS ANALYSIS OF VIRUS LIKE PARTICLES

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL VIRUS LIKE PARTICLES MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Picture of Virus Like Particles
Table Product Specifications of Virus Like Particles
Table Classification of Virus Like Particles
Figure Global Production Market Share of Virus Like Particles by Type in 2016
Figure Adeno-Associated Virus Picture
Table Major Manufacturers of Adeno-Associated Virus
Figure HIV Picture
Table Major Manufacturers of HIV
Figure Hepatitis B Virus Picture
Table Major Manufacturers of Hepatitis B Virus
Figure Hepatitis C Virus Picture
Table Major Manufacturers of Hepatitis C Virus
Figure Other Picture
Table Major Manufacturers of Other
Table Applications of Virus Like Particles
Figure Global Consumption Volume Market Share of Virus Like Particles by Application in 2016
Figure Vaccines Examples
Table Major Consumers in Vaccines
Figure Mycoviruses Examples
Table Major Consumers in Mycoviruses
Figure Virus Research Examples
Table Major Consumers in Virus Research
Figure Therapeutic and Imaging Agents Examples
Table Major Consumers in Therapeutic and Imaging Agents
Figure Other Examples
Table Major Consumers in Other
Figure Market Share of Virus Like Particles by Regions
Figure North America Virus Like Particles Market Size (Million USD) (2012-2022)
Figure China Virus Like Particles Market Size (Million USD) (2012-2022)
Figure Europe Virus Like Particles Market Size (Million USD) (2012-2022)
Figure Southeast Asia Virus Like Particles Market Size (Million USD) (2012-2022)
Figure Japan Virus Like Particles Market Size (Million USD) (2012-2022)
Figure India Virus Like Particles Market Size (Million USD) (2012-2022)
Table Virus Like Particles Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Virus Like Particles in 2016
Figure Manufacturing Process Analysis of Virus Like Particles
Figure Industry Chain Structure of Virus Like Particles
Table Capacity and Commercial Production Date of Global Virus Like Particles Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Virus Like Particles Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Virus Like Particles Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Virus Like Particles Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Virus Like Particles 2012-2017
Figure Global 2012-2017E Virus Like Particles Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Virus Like Particles Market Size (Value) and Growth Rate
Table 2012-2017E Global Virus Like Particles Capacity and Growth Rate
Table 2016 Global Virus Like Particles Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Virus Like Particles Sales (K Pcs) and Growth Rate
Table 2016 Global Virus Like Particles Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Virus Like Particles Sales Price (USD/Pcs)
Table 2016 Global Virus Like Particles Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Virus Like Particles 2012-2017E
Figure North America 2012-2017E Virus Like Particles Sales Price (USD/Pcs)
Figure North America 2016 Virus Like Particles Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Virus Like Particles 2012-2017E
Figure China 2012-2017E Virus Like Particles Sales Price (USD/Pcs)
Figure China 2016 Virus Like Particles Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Virus Like Particles 2012-2017E
Figure Europe 2012-2017E Virus Like Particles Sales Price (USD/Pcs)
Figure Europe 2016 Virus Like Particles Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Virus Like Particles 2012-2017E
Figure Southeast Asia 2012-2017E Virus Like Particles Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Virus Like Particles Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Virus Like Particles 2012-2017E
Figure Japan 2012-2017E Virus Like Particles Sales Price (USD/Pcs)
Figure Japan 2016 Virus Like Particles Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Virus Like Particles 2012-2017E
Figure India 2012-2017E Virus Like Particles Sales Price (USD/Pcs)
Figure India 2016 Virus Like Particles Sales Market Share
Table Global 2012-2017E Virus Like Particles Sales (K Pcs) by Type
Table Different Types Virus Like Particles Product Interview Price
Table Global 2012-2017E Virus Like Particles Sales (K Pcs) by Application
Table Different Application Virus Like Particles Product Interview Price
Table GlaxoSmithKline Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline Virus Like Particles Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 GlaxoSmithKline Virus Like Particles Business Region Distribution
Table Merck Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck Virus Like Particles Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Merck Virus Like Particles Business Region Distribution
Table Novavax Information List
Table Product A Overview
Table Product B Overview
Table 2015 Novavax Virus Like Particles Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Novavax Virus Like Particles Business Region Distribution
Table Takeda Information List
Table Product A Overview
Table Product B Overview
Table 2016 Takeda Virus Like Particles Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Takeda Virus Like Particles Business Region Distribution
Table Medicago Information List
Table Product A Overview
Table Product B Overview
Table 2016 Medicago Virus Like Particles Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Medicago Virus Like Particles Business Region Distribution
Table MedImmune Information List
Table Product A Overview
Table Product B Overview
Table 2016 MedImmune Virus Like Particles Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 MedImmune Virus Like Particles Business Region Distribution
Table TechnoVax Information List
Table Product A Overview
Table Product B Overview
Table 2016 TechnoVax Virus Like Particles Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 TechnoVax Virus Like Particles Business Region Distribution
Table Agilvax Information List
Table Product A Overview
Table Product B Overview
Table 2016 Agilvax Virus Like Particles Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Agilvax Virus Like Particles Business Region Distribution
Table Allergy Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2016 Allergy Therapeutics Virus Like Particles Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Allergy Therapeutics Virus Like Particles Business Region Distribution
Table Serum Institute of India Information List
Table Product A Overview
Table Product B Overview
Table 2016 Serum Institute of India Virus Like Particles Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Serum Institute of India Virus Like Particles Business Region Distribution
Table GeoVax Labs Information List
Table Cytos Biotechnology Information List
Table ANGANY Genetics Information List
Table CPL Biologicals Information List
Table Xiamen Innovax Biotech Information List
Figure Global 2017-2022 Virus Like Particles Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Virus Like Particles Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Virus Like Particles Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Virus Like Particles Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Virus Like Particles Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Virus Like Particles Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Virus Like Particles Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Virus Like Particles Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Virus Like Particles Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Virus Like Particles by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Virus Like Particles by Application 2017-2022
Table Traders or Distributors with Contact Information of Virus Like Particles by Region


More Publications